ImpediMed Limited logo

ImpediMed Limited (IPDQF)

Market Closed
7 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
14.27M Market Cap
- P/E Ratio
- Div Yield
55,000 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0.04
Want to track IPDQF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

IPDQF closed Friday higher at $0, an increase of 0% from Thursday's close, completing a monthly decrease of -34% or $0. Over the past 12 months, IPDQF stock lost -86.6935%.
IPDQF is not paying dividends to its shareholders.
The last earnings report, released on Feb 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
ImpediMed Limited has completed 1 stock splits, with the recent split occurring on Nov 17, 2014.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on ASX (AUD).

IPDQF Chart

People also search for

Decker Manufacturing Corporation
$ 57.01
0%
Cannabix Technologies Inc.
$ 0.37
-6.775%
VicapSys Life Sciences Inc.
$ 1.45
0%
Nuo Therapeutics Inc.
$ 0.85
0%
Quantumzyme Corp.
$ 0.8
+33.3333%

ImpediMed Limited (IPDQF) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

ImpediMed Limited is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is IPDQF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 14.27M.

Has ImpediMed Limited ever had a stock split?

ImpediMed Limited had 1 splits and the recent split was on Nov 17, 2014.

ImpediMed Limited Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Erik Anderson CEO
OTC PINK Exchange
AU000000IPD8 ISIN
AU Country
83 Employees
- Last Dividend
1 Jun 2009 Last Split
24 Oct 2007 IPO Date

Overview

ImpediMed Limited is an innovative medical technology company based in Pinkenba, Australia, with a global outreach spanning across Australia, North America, and beyond. Founded in 1999, the company specializes in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) devices alongside software services. These devices are pivotal in the non-invasive assessment of body composition, fluid status, and the specific medical condition of lymphedema. ImpediMed's mission revolves around delivering cutting-edge solutions that cater to various sectors within the healthcare industry, including hospitals and clinics, thereby playing a crucial role in advancing patient care and treatment outcomes.

Products and Services

  • SOZO:
  • A flagship product of ImpediMed, SOZO, is a state-of-the-art noninvasive BIS device designed for the comprehensive assessment of lymphedema. Beyond its primary function, SOZO provides a quick snapshot of a patient's fluid status and tissue composition, which is invaluable for healthcare providers in managing and treating conditions related to fluid imbalance and tissue composition. This technology underscores ImpediMed's commitment to innovative solutions that enhance patient care and health management.

  • SFB7:
  • The SFB7 is another offering from ImpediMed’s portfolio, aimed at analyzing body composition in healthy individuals. As a single-channel, tetrapolar BIS device, it exemplifies the fusion of technology and healthcare to deliver accurate, valuable insights into body composition. This device is particularly geared towards use in wellness and fitness settings, marking ImpediMed’s expansion into diverse healthcare facets.

  • ImpediVET:
  • Expanding the utility of its BIS technology, ImpediMed has ventured into veterinary care with the introduction of ImpediVET. This single-channel, tetrapolar BIS device is crafted for veterinary applications, measuring fluid status and tissue composition in animals. ImpediVET signifies ImpediMed’s innovative approach to healthcare, tailoring its cutting-edge technology for use in veterinary practices, thereby contributing to the enhancement of animal care and treatment.

Contact Information

Address: 50 Parker Court
Phone: 61 7 3860 3700